cre治疗解读 ppt

biolClin. 2014Dec;32Suppl4:33-40.4.JaruratanasirikulSetal.JournalofAnTimicrobialChemoTherapy2009;63:560–563.5.JoseF.Camargo,etal.AntimicrobialAgentsandChemotherapy.2015;59(10):5903-5908.6.JournalofAntimcirobialChemotherapy.65(6):1119-1125.7.王立新,等.国际流行病学传染病学杂志.2011;38(5):349-351.6国内外指南对于CRE治疗的推荐1,21.TheSanfordGuidetoAntimicrobialTherapy,43thEdition,2013.2.ChineseXDRConsensusWorkingGroup.ClinMicrobiolInfect.2016Mar;22Suppl1:S15-25.7BJCarba11-15CAGR12.5%VSG-mkt11-15CAGR3.1%BJperformance20112012201320142015CarbaY/YGR-0.39.38.219.413.4CarbaEV122.7116.3100.8112.1107.8碳青霉烯类的市场份额和增长率碳青霉烯的金额(MUSD)北京革兰阴性菌治疗市场中?碳青霉烯类的使用趋势Datasource:IMSexchange:6.2532.8欧洲CRE对碳青霉烯类的MIC值比国内低CantónR,etal.MicrobiolClin. 2014Dec;32Suppl4:33-40.9我国CRE对碳青霉烯类的MIC值以≥16mg/L为主XuA,etal.ClinMicrobiolInfect.2016Mar;22Suppl1:S1-8.10